scholarly journals A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

2020 ◽  
Vol 26 (3) ◽  
pp. S274
Author(s):  
Susan E Prockop ◽  
Minoti Hiremath ◽  
Wei Ye ◽  
Laurence Gamelin ◽  
Willis H. Navarro ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document